InvestorsHub Logo
Followers 62
Posts 7498
Boards Moderated 1
Alias Born 01/02/2003

Re: JRoon71 post# 422637

Saturday, 03/30/2024 12:30:42 PM

Saturday, March 30, 2024 12:30:42 PM

Post# of 423944
JR..."exclusive contracts that reduce competition may also violate the Sherman Antitrust Act and are subject to civil enforcement. "

The PBM's (pharmacy benefit managers) negotiate exclusive contracts with generic companies, which stipulate lower prices for the generic company's product...in return for the PBM refusing to list a competitor's product...

This common practice seems a clear violation of anti-trust laws...When Amarin eventually tries to list an AG( authorized generic) for Vascepa, Amarin's sole drug) with a PBM, this illegal practice of exclusivity will present a formidable challenge to Amarin....as opposed to generic companies that which have many products to list with a PBM.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News